NNC-07-0775

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNNC-07-0775
Drug Alias NameNNC-07-0775
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor antagonistsGlutamate receptor ionotropic AMPA antagonists
TargetsMetabotropic glutamate receptorGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsEpilepsyAlzheimer DiseaseStroke +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsEpilepsyAlzheimer DiseaseStroke +[4] 

Other Information

ATC CodeN/A
Related LinksN/A